# | Title | Journal | Year | Citations |
---|
1 | The Hippo pathway and human cancer | Nature Reviews Cancer | 2013 | 1,479 |
2 | Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study | Lancet, The | 2020 | 1,108 |
3 | Perforin and granzymes: function, dysfunction and human pathology | Nature Reviews Immunology | 2015 | 858 |
4 | [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study | Lancet Oncology, The | 2018 | 823 |
5 | Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis | Nature Medicine | 2018 | 689 |
6 | Lymphangiogenesis and lymphatic vessel remodelling in cancer | Nature Reviews Cancer | 2014 | 621 |
7 | Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis | European Urology | 2020 | 614 |
8 | [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial | Lancet, The | 2021 | 552 |
9 | The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant | Cancer Treatment Reviews | 2015 | 482 |
10 | Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53 | Cancer Cell | 2012 | 468 |
11 | BET inhibitor resistance emerges from leukaemia stem cells | Nature | 2015 | 441 |
12 | Gene-engineered T cells for cancer therapy | Nature Reviews Cancer | 2013 | 425 |
13 | The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions | Nature Immunology | 2014 | 410 |
14 | CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 406 |
15 | Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil | Gastroenterology | 2013 | 381 |
16 | An Immunosurveillance Mechanism Controls Cancer Cell Ploidy | Science | 2012 | 367 |
17 | Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia | Molecular Therapy | 2013 | 361 |
18 | An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer | Cancer Cell | 2019 | 359 |
19 | Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade | Clinical Cancer Research | 2020 | 355 |
20 | Abscopal effects of radiation therapy: A clinical review for the radiobiologist | Cancer Letters | 2015 | 354 |
21 | Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments | Seminars in Cancer Biology | 2018 | 314 |
22 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer | Journal of the National Cancer Institute | 2015 | 311 |
23 | Strategies for the discovery and development of therapies for metastatic breast cancer | Nature Reviews Drug Discovery | 2012 | 310 |
24 | Impact of Coronavirus Disease 2019 Public Health Measures on Detections of Influenza and Respiratory Syncytial Virus in Children During the 2020 Australian Winter | Clinical Infectious Diseases | 2021 | 309 |
25 | Blockade of A 2A receptors potently suppresses the metastasis of CD73 + tumors | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 306 |
26 | A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer | Journal of Hematology and Oncology | 2013 | 301 |
27 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | Nature Genetics | 2017 | 289 |
28 | Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes | Journal of Nuclear Medicine | 2019 | 285 |
29 | Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 | European Urology | 2020 | 278 |
30 | Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families | Journal of Clinical Oncology | 2020 | 270 |
31 | MDM4 is a key therapeutic target in cutaneous melanoma | Nature Medicine | 2012 | 266 |
32 | Targeting the epigenetic regulation of antitumour immunity | Nature Reviews Drug Discovery | 2020 | 264 |
33 | Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls | Radiographics | 2018 | 262 |
34 | Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML | Cell Stem Cell | 2018 | 249 |
35 | VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium | Cancer Cell | 2012 | 244 |
36 | Tumor immune evasion arises through loss of TNF sensitivity | Science Immunology | 2018 | 244 |
37 | Prostate cancer | Lancet, The | 2021 | 240 |
38 | The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019–Related Public Health Measures | Clinical Infectious Diseases | 2021 | 236 |
39 | Li-Fraumeni syndrome: cancer risk assessment and clinical management | Nature Reviews Clinical Oncology | 2014 | 218 |
40 | Immunosuppressive activities of adenosine in cancer | Current Opinion in Pharmacology | 2016 | 216 |
41 | Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry | Nature Communications | 2019 | 210 |
42 | The nucleolus: an emerging target for cancer therapy | Trends in Molecular Medicine | 2013 | 205 |
43 | Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing | BMC Medical Genomics | 2014 | 200 |
44 | The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper | Critical Reviews in Oncology/Hematology | 2019 | 200 |
45 | Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection | Science | 2013 | 197 |
46 | Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study | European Urology | 2014 | 195 |
47 | FDG PET/CT for assessing tumour response to immunotherapy | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 194 |
48 | E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 188 |
49 | Genome-wide association study identifies two susceptibility loci for osteosarcoma | Nature Genetics | 2013 | 181 |
50 | Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy | Blood | 2015 | 181 |